FDA Adverse Event Malfunction Summary report: N

GYNECARE MORCELLEX* TISSUE MORCELLATOR

MDR report key: 2534246 · Received April 12, 2012

Report

Report Number
2210968-2012-01089
Event Type
Malfunction
Date Received
April 12, 2012
Date of Event
March 23, 2012
Report Date
March 23, 2012
Manufacturer
ETHICON, INC.
Product Code
HET
PMA / PMN Number
K100280
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TN, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

CONCLUSION: THE ACTUAL DEVICE INVOLVED IN THIS EVENT WAS RETURNED FOR EVALUATION. THE DEVICE WAS VISUALLY AND FUNCTIONALLY EVALUATED. THE BLADE FAILED TO ROTATE DURING THE EVALUATION.

Additional Manufacturer Narrative · 1

(B)(4) - BLADE SEIZED/STOPPED. CONCLUSION: THE PRODUCT UPON WHICH THIS MEDWATCH IS BASED HAS BEEN RECEIVED, HOWEVER, THE PRODUCT EVALUATION IS NOT YET COMPLETE. ANY FURTHER INFORMATION DERIVED FROM THE EVALUATION WILL BE SUBMITTED IN A SUPPLEMENTAL 3500A FORM. IN ADDITION, A REVIEW OF THE BATCH MANUFACTURING RECORDS WAS CONDUCTED AND THE BATCH MET ALL FINISHED GOODS RELEASE CRITERIA. THIS IS ONE OF FOUR MEDWATCHES BEING SUBMITTED AS FOUR DEVICES WERE INVOLVED IN THIS EVENT. SEE ALSO MEDWATCHES 2210968-2012-01088, 2210968-2012-01090, AND 2210968-2012-01091. THE SAME PATIENT IS REPRESENTED IN EACH MEDWATCH. THIS MEDWATCH REPORT IS IN RESPONSE TO RECEIPT OF FACILITY REPORT # (B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT A PATIENT UNDERWENT A DA VINCI-ASSISTED LAPAROSCOPIC MYOMECTOMY WITH LYSIS OF ADHESIONS ON (B)(6) 2012. DURING THE PROCEDURE, THE DEVICE FUNCTIONED INTERMITTENTLY, THEN STOPPED CUTTING. THE DEVICE WAS TRIED IN FULL AND IN COREGUARD MODE WHEN TROUBLE SHOOTING, BUT IT STOPPED MORCELLATING. THE DEVICE BECAME INOPERARABLE. ANOTHER LIKE DEVICE WAS USED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GYNECARE MORCELLEX* TISSUE MORCELLATOR LAPAROSCOPE, GYNECOLOGIC HET ETHICON, INC. NA MT215917

Patients

Seq Age Sex Outcome Treatment
1 38 YR